Mercado europeo de aisladores farmacéuticos: tendencias de la industria y pronóstico hasta 2029

Análisis y perspectivas del mercado de aisladores farmacéuticos en Europa

Los aisladores farmacéuticos se utilizan en la industria farmacéutica como un sistema de barrera libre de contaminación. Las pruebas microbiológicas, el procesamiento de terapia celular, la fabricación farmacéutica avanzada (ATMP) y el pesaje, envasado y distribución de productos inyectables estériles son solo algunas de las aplicaciones de los aisladores farmacéuticos. El uso de aisladores farmacéuticos se ve impulsado por el crecimiento continuo del mercado farmacéutico en los países en desarrollo y desarrollados y el aumento de los gastos de I+D para producir tratamientos innovadores. Los aisladores médicos avanzados y los requisitos de la industria farmacéutica han llevado a los principales fabricantes a hacer crecer la industria de aisladores médicos. El uso creciente de compuestos peligrosos, el aumento del costo del incumplimiento y el aumento de los laboratorios de investigación son factores importantes que impulsan el mercado de aisladores farmacéuticos durante el período de pronóstico.

Sin embargo, la mayoría de los expertos no están de acuerdo en que las entidades reguladoras ya no impidan avances como el desarrollo de aislantes farmacéuticos.

Data Bridge Market Research analiza que se espera que el mercado europeo de aisladores farmacéuticos alcance un valor de USD 1.857,44 millones para 2029, con una CAGR del 13,8 % durante el período de pronóstico. El tipo representa el segmento de tipo más grande en el mercado debido a la rápida demanda de aisladores farmacéuticos en la región. Este informe de mercado también cubre en profundidad el análisis de precios, el análisis de patentes y los avances tecnológicos.

Definición del mercado europeo de aisladores farmacéuticos

El concepto de aislamiento protege el proceso del operador y/o al operador del proceso, al mismo tiempo que protege el medio ambiente. La clave para la contención es una exposición mínima. Al controlar el rango de exposición por debajo del nivel de riesgo establecido para el compuesto, el operador y el medio ambiente están adecuadamente protegidos. Por lo tanto, el producto está protegido y, por lo tanto, se aborda un problema regulatorio clave. Un aislador farmacéutico es un recinto bacteriano sellado que se utiliza en el entorno farmacéutico para el llenado aséptico y el proceso tóxico. Está hecho de un aislador principal perfectamente estéril donde los productos se manipulan, almacenan o envasan utilizando guantes a la altura de los hombros colocados en una de las paredes. El aislador farmacéutico permite el control y la contención de los procesos farmacéuticos. Las condiciones requeridas para el funcionamiento de un aislador farmacéutico son un entorno estéril y libre de microorganismos viables. Un aislador farmacéutico garantiza que el área de producción y el entorno aséptico se coloquen en posiciones separadas. Un aislador de la industria farmacéutica es rentable y eficiente, en comparación con las salas blancas para la industria farmacéutica en un entorno aséptico. Crea una atmósfera controlada durante el proceso de producción microbiana y de fármacos ajustándose a los diferentes estándares de certificación exigidos para aisladores y barreras de acceso restringido, garantizando al mismo tiempo la protección del producto, de los operarios y del medio ambiente.

The abundant applications of pharmaceutical isolators, vary for production and control purposes. It is used while handling, transferring or packing solid semi-solid or powder pharma drugs, handling and filing solutions and infusions. The pharmaceutical isolators are applied in sterility testing, aseptic handling of tissues or biological production systems or pathogenic samples, etc. It can be used for the production and control of drugs and pharmaceutical products. The surge in demand for the isolators across pharmaceutical and biotechnology industry, along with low operational cost, high maintenance of aseptic condition in the production of pharmaceutical products and growing demand of biopharmaceutical industry are the factors expected to drive the market growth, in the forecast period.

Also, strategic initiative by market players, technological progressions in pharmaceutical isolators, high sterility assurance and increasing investment for healthcare infrastructure. These factors increase in the demand for pharmaceutical isolators market.

Europe Pharmaceutical Isolator Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:    

Drivers

Growing demand for the pharmaceutical isolators across booming pharmaceutical

Pharmaceutical isolator is a separative device that divides a pharmaceutical procedure or activity from the operator and the adjacent environment. It is used for various purposes such as:

• Providing a categorized aseptic environment for an activity or procedure and guarding it from microbial and non-microbial contamination rising from the operator and adjacent environment which is referred to product protection.
• Protective product from contamination produced by other product and procedure, moreover at the same time or during earlier operations. This is referred to as safeguard against method generated contamination or cross- contamination.

The Increasing contamination problems in the manufacturing unit in which comes isolator that create a demand for Pharmaceutical isolator that helps in contamination and de-contamination.

• Low operational cost of pharmaceutical isolators

Enclosures that are sealed to some standard of leak tightness that comprises inside qualified controlled environment, at modification with the surrounding conditions isolator application reaches from R&D by the production of pharmaceuticals to laboratory use, especially for the microbiological quality control. Whereas pharmaceutical aseptic production has extremely high standards of cleanness almost completely particle free and germ free environments for the aseptic production.

Due to growth in the pharma industry and the widening product range more and more manufacturers and suppliers needs to think about investments in latest added technologies of the clean room technology.

Aseptic processing of the pharmaceutical drugs is the major factor need to be included in good manufacturing practices meeting the government regulations. The high cost of the maintenance of the aseptic condition by clean room technology which is around 62% higher than the pharmaceutical isolators, shifting the manufacturers to acquire isolator’s technology and constraining the overall manufacturing cost of the pharmaceutical products.

Restraint

Stringent governmental regulations

Active Pharmaceutical Ingredients (API) and intermediates for pharmaceutical use (for instance biological, radiopharmaceutical, and pharmaceutical) and those used to production drugs for clinical trials are regulated under the Divisions 1A and 2, Part C of the Food and Drug Regulations.

• Division 1A, Part C of the Food and Drug Regulations describes activities for which Good Manufacturing Practices (GMP) compliance is required and must be demonstrated prior to the issuance of an API establishment license (EL).
• Division 2, Part C of the Food and Drug Regulations defines the requirements for the GMP of APIs and API intermediates, which are interpreted in the present guidance document.

Due to this strict regulation by the government that has to be followed for the production by the Good Manufacturing Practices (GMP) Guidelines for Active Pharmaceutical Ingredients (API) - (GUI-0104) which constraining the market growth rate.

Opportunity

• Strategic initiatives by market players

The rise in the pharmaceutical isolators market increases the need for strategic business ideas. It includes a partnership, business expansion, and other development. The rising demand for pharmaceuticals is significantly increasing the demand for excipient and to cope with this demand companies are building new manufacturing sites among other strategic initiatives.

These strategic initiatives such as product launches, agreement and business expansion by the major market player will boost the pharmaceutical isolator market growth and is expected to act as an opportunity for the Europe medical display market.

Challenge

Lack of skilled expertise

The shortage of skilled expertise would challenge the pace of recovery and growth in one place. Often, the people who are unemployed in one place have skills that are in short supply elsewhere. Moreover, rapid technological advancement in this field also leads to lack of expertise.

Lack of skilled professionals while handling the pharmaceutical isolators poses a major challenge while selecting and developing the pharmaceutical isolators. The data by the Phys.org 2003 mentions the medical display industries are facing a shortage of workers due to increase demand of pharmaceutical isolators in Asia-Pacific region and severe scarcity of micro chips used in LED and LCD display, which increases the price lead times of LCD production.

As skill demands are too high, it has manifested as a challenge to retain and manage skill-specified professionals. Moreover, technological advancement is another aspect that leads to the increased demand for skilled professionals. Neurologists report significant unmet supportive care needs and barriers in their centers with only a small minority rating themselves as competently providing supportive care. There is an urgent need for education of neurologists and professionals for treatment of dementia and procuring available supportive care resources. Lack of trained and experienced professionals and persistent skill gaps limit the employability prospects and access to quality jobs. It is therefore apparent that availability of professionals equipped with adequate skills is expected to challenge the market growth.

Post-COVID-19 Impact on Europe Pharmaceutical Isolator Market

The COVID-19 pandemic has become the world's most serious threat. It wreaked havoc in many stores and businesses around the world. The pandemic, on the other hand, has provided many opportunities for pharmaceutical and biopharmaceutical companies to expand their research and development activities to develop new vaccines against the new coronavirus. Companies are conducting clinical trials to try to stop the spread of the COVID-19 virus. Pharmaceutical insulator suppliers to biopharmaceutical organizations have more opportunities as the number of clinical trials increases.

Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launch and strategic partnerships to improve the technology and test results involved in the pharmaceutical medical display market.

Recent Developments

• In June 2022, the company announced a partnership with Medical Supply Company (MSC) to market and service Jacomex equipment to the pharmaceutical and pharmaceutical industries in Ireland. MSC has many years of recognized expertise in the market with field teams closest to customers and company’s commercial team currently working abroad had the pleasure of welcoming Cian Murphy and finalizing the agreement between Jacomex and MSC. The beginning of a long and fruitful collaboration. This has helped the company to expand their business.
• In January 2022, Clario partnered with XingImaging, a radiopharmaceutical production and positron emission tomography (PET) acquisition company, to deliver PET imaging clinical trials for testing novel therapeutics in China. The partnership offers to share the joint resources and neuroscience experts of Clario and XingImaging to expedite the startup of clinical trials and drug discovery in China.

Europe Pharmaceutical isolator market Scope

Europe pharmaceutical isolator market is segmented into type, pressure, application, configuration, system type, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY TYPE

• ASEPTIC ISOLATORS
• CONTAINMENT ISOLATORS
• BIO ISOLATORS
• SAMPLING AND WEIGHING ISOLATORS
• ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS
• RADIOPHARMACEUTICAL ISOLATORS
• PRODUCTION ISOLATORS
• OTHERS

On the basis of type, the Europe pharmaceutical isolator market is segmented into aseptic isolators, containment isolators, bio isolators, sampling and weighing isolators, active pharmaceutical ingredient (API) manufacturing isolators, radiopharmaceutical isolators, production isolators, others.

EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE

• CLOSED SYSTEM
• OPEN SYSTEM

On the basis of system type, the Europe pharmaceutical isolator market is segmented into closed system, open system.

EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE

• POSITIVE PRESSURE
• NEGATIVE PRESSURE

On the basis of pressure, the Europe pharmaceutical isolator market is segmented into positive pressure and negative pressure.

EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION

• FLOOR STANDING
• MODULAR
• MOBILE
• COMPACT
• TABLE TOP
• PORTABLE
• OTHERS

On the basis of configuration, the Europe pharmaceutical isolator market is segmented into floor standing, modular, mobile, compact, table top, portable, others.

EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY APPLICATION

• STERILITY TESTING
• MANUFACTURING
• SAMPLING/ WEIGHING/ DISTRIBUTION
• MEDICAL DEVICE MANUFACTURING
• OTHERS

On the basis of application, the Europe pharmaceutical isolator market is segmented into sterility testing, manufacturing, sampling/ weighing/ distribution, medical device manufacturing, others.

EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY END USER

• HOSPITALS
• DIAGNOSTIC LABORATORIES
• ACADEMIC AND RESEARCH INSTITUTES
• PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
• CONTRACT RESEARCH ORGANIZATIONS
• OTHERS

On the basis of end user, the Europe pharmaceutical isolator market is segmented into hospitals, diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, others.

EUROPE PHARMACEUTICAL ISOLATOR MARKET, BY DISTRIBUTION CHANNEL

• DIRECT TENDER
• RETAIL SALES
• THIRD PARTY DISTRIBUTORS

On the basis of distribution channel, the Europe pharmaceutical isolator market is segmented into direct tender, retail sales, third party distributors.

Europe Pharmaceutical Isolator Market Regional Analysis/Insights

The Europe pharmaceutical isolator market is analyzed and market size information is provided type, pressure, application, configuration, system type, end user and distribution channel.

The countries covered in this market report Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland and the rest of Europe.

In 2022, Germany is dominating due to rapidly growing pharmaceutical market coupled with rise in pharmaceutical equipments production and increasing demand from emerging markets and expansion of healthcare industries.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Europe Pharmaceutical Isolator Market Share Analysis

Europe pharmaceutical isolator market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the Europe pharmaceutical isolator market.

Some of the major players operating in the Europe pharmaceutical isolator market are Getinge, SKAN AG, Hosokawa micron ltd, Gelman Singapore, Azbil Corporation, Germfree Laboratories, Inc., M. Braun Inertgas-Systeme Gmbh, Nuaire, Iteco S.R.L., Comecer S.P.A., Hecht Technologie Gmbh, Steriline S.R.L., Envair Limited, Tema Sinergie S.P.A, Schematic Engineering Industries, Chiyoda Corporation, Chamunda Pharma Machinery Pvt. Ltd, Bioquell (Ecolab Solution), Jacomex, Fedegari Autoclavi S.p.A., LAF Technologies, ISO Tech Design, Cytiva, Esco Pharma.

Research Methodology: Europe Pharmaceutical Isolator Market

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con tamaños de muestra grandes. Los datos del mercado se analizan y estiman utilizando modelos estadísticos y coherentes del mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Aparte de esto, los modelos de datos incluyen la cuadrícula de posicionamiento de proveedores, el análisis de la línea de tiempo del mercado, la descripción general y la guía del mercado, la cuadrícula de posicionamiento de la empresa, el análisis de la participación de mercado de la empresa, los estándares de medición, Europa frente a la región y el análisis de la participación de los proveedores. Solicite una llamada de un analista en caso de tener más consultas.

SKU-35223